NEW YORK (GenomeWeb News) – Celera’s registration statement with the US Securities and Exchange Commission was declared effective yesterday by the regulatory body, clearing the way for Celera’s formal separation from sister company Applied Biosystems and parent firm Applera.
The split will take place at 12:01 a.m. EDT, on July 1, subject to certain conditions, including receipt of certain contents and listing of Celera’s stock on the Nasdaq, according to an Applera statement.
Celera had filed for the split in April. Under terms of the separation, shareholders of the Applera Group-Celera Group tracking stock will receive one share of new Celera Corporation shares for each share of the tracking stock they currently own. Upon completion of the deal, Celera will become an independent, publicly traded company.
Celera will trade on the Nasdaq under its current ticker symbol, CRA, and its current tracking stock will be delisted from the New York Stock Exchange.